跳至主要内容
临床试验/JPRN-jRCTs051210106
JPRN-jRCTs051210106暂停2 期

The Effect of Suplatast Tosilate for interstitial Cystitis: A randomized controlled open-label trial - ESTOC study

Torimoto Kazumasa0 个研究点目标入组 100 人开始时间: 2021年10月13日最近更新:
适应症

试验速览

阶段
2 期
状态
暂停
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients diagnosed as IC

排除标准

  • 1) Patients who are allergic to the treatment drug
  • 2) Patients with serious liver disease (AST (GOT) or ALT (GPT) 100 IU / L or higher)
  • 3) Patients who are pregnant or may become pregnant
  • 4) Patients who took the study drug within 3 months before the start of study drug administration
  • 5) Patients who are judged to be inappropriate as subjects by the investigator

研究者

发起方
Torimoto Kazumasa

相似试验

ESTOC study | 临床试验